![]() |
Name |
Hexadecyl trichloroacetate
|
Molecular Formula | C18H33Cl3O2 | |
IUPAC Name* |
hexadecyl 2,2,2-trichloroacetate
|
|
SMILES |
CCCCCCCCCCCCCCCCOC(=O)C(Cl)(Cl)Cl
|
|
InChI |
InChI=1S/C18H33Cl3O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-23-17(22)18(19,20)21/h2-16H2,1H3
|
|
InChIKey |
CCFJXGUHYQBXDT-UHFFFAOYSA-N
|
|
Synonyms |
Hexadecyl trichloroacetate; hexadecyl 2,2,2-trichloroacetate; 74339-54-1; Trichloroacetic acid, hexadecyl ester; n-hexadecyltrichloroacetate; Hexadecyl trichloroacetate #; TRICHLOROACETIC ACID PALMITYL ESTER*(C16 ); DTXSID30334986; CHEBI:151087; Trichloroacetic acid, palmityl ester; Acetic acid, trichloro-, hexadecyl ester; Trichloroacetic acid palmityl ester*(c16)
|
|
CAS | 74339-54-1 | |
PubChem CID | 522536 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 387.8 | ALogp: | 9.6 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 23 | QED Weighted: | 0.165 |
Caco-2 Permeability: | -5.338 | MDCK Permeability: | 0.00003090 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.001 |
30% Bioavailability (F30%): | 0.072 |
Blood-Brain-Barrier Penetration (BBB): | 0.397 | Plasma Protein Binding (PPB): | 99.29% |
Volume Distribution (VD): | 2.266 | Fu: | 1.34% |
CYP1A2-inhibitor: | 0.537 | CYP1A2-substrate: | 0.197 |
CYP2C19-inhibitor: | 0.663 | CYP2C19-substrate: | 0.225 |
CYP2C9-inhibitor: | 0.298 | CYP2C9-substrate: | 0.874 |
CYP2D6-inhibitor: | 0.125 | CYP2D6-substrate: | 0.04 |
CYP3A4-inhibitor: | 0.248 | CYP3A4-substrate: | 0.169 |
Clearance (CL): | 4.533 | Half-life (T1/2): | 0.06 |
hERG Blockers: | 0.472 | Human Hepatotoxicity (H-HT): | 0.005 |
Drug-inuced Liver Injury (DILI): | 0.155 | AMES Toxicity: | 0.753 |
Rat Oral Acute Toxicity: | 0.013 | Maximum Recommended Daily Dose: | 0.017 |
Skin Sensitization: | 0.95 | Carcinogencity: | 0.309 |
Eye Corrosion: | 0.991 | Eye Irritation: | 0.953 |
Respiratory Toxicity: | 0.915 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000424 | ![]() |
0.754 | D07ILQ | ![]() |
0.570 | ||
ENC001163 | ![]() |
0.696 | D0Z5SM | ![]() |
0.553 | ||
ENC001243 | ![]() |
0.688 | D00FGR | ![]() |
0.527 | ||
ENC001157 | ![]() |
0.671 | D00AOJ | ![]() |
0.506 | ||
ENC002300 | ![]() |
0.671 | D05ATI | ![]() |
0.480 | ||
ENC000356 | ![]() |
0.662 | D0O1PH | ![]() |
0.429 | ||
ENC000496 | ![]() |
0.658 | D00STJ | ![]() |
0.359 | ||
ENC000575 | ![]() |
0.653 | D0T9TJ | ![]() |
0.350 | ||
ENC001234 | ![]() |
0.653 | D0P1RL | ![]() |
0.350 | ||
ENC001218 | ![]() |
0.646 | D00MLW | ![]() |
0.333 |